La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.

PubblicatoCaterina Blasi Modificato 9 anni fa

Presentazioni simili

Presentazione sul tema: "Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the."— Transcript della presentazione:

1 Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols by Massimo Breccia, Luca Mazzarella, Vincenzo Bagnardi, Davide Disalvatore, Giuseppina Loglisci, Giuseppe Cimino, Anna Maria Testi, Giuseppe Avvisati, Maria Concetta Petti, Clara Minotti, Roberto Latagliata, Robin Foà, Pier Giuseppe Pelicci, and Francesco Lo-Coco Blood Volume 119(1):49-54 January 5, 2012 ©2012 by American Society of Hematology

2 Relationship between BMI, on a continuous scale, and the hazard of relapse. Massimo Breccia et al. Blood 2012;119:49-54 ©2012 by American Society of Hematology

3 Cumulative incidence of relapse according to BMI. Massimo Breccia et al. Blood 2012;119:49-54 ©2012 by American Society of Hematology

Scaricare ppt "Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the."

Presentazioni simili

Fissatore esterno Estrema rapidità di impiego in mani esperte

Fissatore esterno Estrema rapidità di impiego in mani esperte
Basi farmacologiche della terapia dell’ipertensione

Basi farmacologiche della terapia dell’ipertensione
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.
Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.

Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.
Heterotropic Effectors Exert More Significant Strain on Monoligated than on Unligated Hemoglobin Massimo Coletta, Mauro Angeletti, Isabella Ascone, Giovanna.

Heterotropic Effectors Exert More Significant Strain on Monoligated than on Unligated Hemoglobin Massimo Coletta, Mauro Angeletti, Isabella Ascone, Giovanna.
Complex Segmental Duplications Mediate a Recurrent dup(X)(p11.22-p11.23) Associated with Mental Retardation, Speech Delay, and EEG Anomalies in Males and.

Complex Segmental Duplications Mediate a Recurrent dup(X)(p11.22-p11.23) Associated with Mental Retardation, Speech Delay, and EEG Anomalies in Males and.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.
With the participation of and supported by I Contratti di fiume per la buona governance di acqua e territorio Massimo Bastiani Coordinatore del Tavolo.

With the participation of and supported by I Contratti di fiume per la buona governance di acqua e territorio Massimo Bastiani Coordinatore del Tavolo.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.
Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.

Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.
Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.

Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.
Problematiche nutrizionali nell ʼ adulto e nell ʼ anziano: paziente con BPCO e paziente con diabete. Dr. V. Emanuele.

Problematiche nutrizionali nell ʼ adulto e nell ʼ anziano: paziente con BPCO e paziente con diabete. Dr. V. Emanuele.
Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,
PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.

PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.
Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.

Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.
Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.

Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.
UP-TO-DATE SULL’ISCHEMIA CRITICA Influenza dei fattori di rischio Andrea Semplicini Medicina Interna 1 - Ospedale di Venezia Azienda ULSS 12 Veneziana.

UP-TO-DATE SULL’ISCHEMIA CRITICA Influenza dei fattori di rischio Andrea Semplicini Medicina Interna 1 - Ospedale di Venezia Azienda ULSS 12 Veneziana.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,

Presentazioni simili

Annunci Google